Explore Crisil, a company of S&P Global
Formerly known as Global Research & Risk Solutions
Investment Banking and Broker Research Strategic partner for global investment banks for high-end research and analytics, and superior origination and execution of mandates
We offer a comprehensive suite of services across research and investment banking backed by our extensive experience of capital markets that helps clients drive revenue growth as well as improve operational efficiencies. With our deep sector and domain expertise, analytics know-how, and sustainability insights, we partner with clients to differentiate their research franchise and enhance banking business outcomes, via bespoke solutions.
2
Over two decades of experience in research and analytics
20+
Cater to 15 of top 20 global investment banks and 20+ regional sell-side firms
3400+
3,300+ stocks and 3,400+ credits covered
800+
800+ research analysts globally
Our solution components
Broker Research
High-end research and analytics solutions offering superior value in a cost-effective manner
Learn more
Investment Banking
End-to-end support driving banking business outcomes
Sustainability
Bespoke solutions and services to enhance and accelerate sustainability integration
Data Analytics and AI
Transforming research solutions with analytics and AI powered accelerators
Crisil Advantage
Subject matter experts across sectors and asset classes for differentiated insights
Multi-language support, spanning geographies and time zones
Scalable and customizable operating models to suit varied client requirements
Robust risk and compliance practices
The problems we solve
Investment Research
Case Studies
'Platform value' estimation of gene editing companies through event impact analysis
Read more
Partnering with a Global Investment Bank across its Asia Research Function
Research Support
End-to-End editorial support for one of the Sell-Side's Marquee Research Providers
Turning scattered market data into meaningful business insights
Mutual fund case
Transforming scattered data into actionable insights for smarter business strategies
Position a US Regional Bank as a Thought Leader in Biotech
Recognitions
The confidence we deliver is felt across boardrooms, markets, and industries.
#37 in Chartis RiskTech 100 | 2025
Chartis RiskTech 100 Model Validation | 2025
#49 in Chartis RiskTech 100 | 2024
Chartis RiskTech 100 Model Validation | 2024
Best Companies for women India | 2024
Read more on our recognitions
Explore Crisil, a company of S&P Global